In Moline, Illinois, long winters and limited specialist access can make weight management harder than it should be. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly since 2022. Weight Method offers a separate option: licensed Illinois providers evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program for Moline starts at $329/month — medication, provider evaluation, ongoing care, and shipping included.
FDA-approved Mounjaro prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Moline is already seeing results
Mounjaro in Moline, IL: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Mounjaro to patients in Moline from $329/month with virtual consultations and direct-to-door shipping.
Tirzepatide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Eli Lilly developed Mounjaro® as the FDA-approved Injectable pen product, taken Once weekly, approved in 2022. Weight Method is a separate program: licensed providers in Illinois evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program for eligible Moline, IL residents starts at $329/month.
Moline's suburban communities are hearing more about GLP-1 treatments through word of mouth and national media. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly since 2022. Weight Method's separate program is straightforward: an online assessment, a virtual provider consultation, and compounded Tirzepatide delivered to your Moline address at $329/month. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Illinois and start Mounjaro from $329/month.
Get Started NowFree consultation. No commitment.